2019-nCoV IgG & IgM A Diagnostic Solution for COVID-19 COVID-19 is a diseased caused by the novel coronavirus (2019-nCoV). The disease can be screened and diagnosed by measuring the antibody IgG & IgM for this virus. Antibody IgM appears in the early stage of infection, while Antibody lgG in the late stage.
Test kits Novel Coronavirus (2019-nCoV) IgG/IgM Test Kit Novel Coronavirus (2019-nCoV) IgG Test Kit Novel Coronavirus (2019-nCoV) IgM Test Kit
Features Colloidal Gold Qualitative testing with minimal interference 25T with individual pouch for each test Whole blood, serum and plasma Low sample volume (W.B. 20uL, S/P 10uL) Rapid results within 15 minutes Storage at room temperature
* Take 2019-nCoV IgG/IgM test kit for example
Interpretation If the viral nucleic acid test is negative, yet the patient is suspected, antibody lgM and lgG should be tested.
IgM (+) / IgG (-)
IgM (+) / IgG (+)
IgM (-) / IgG (+)
It may be an acute infection. Reexamination is recommended one week later
It may be an acute infection. Reexamination is recommended one week later
IgG false positive or previous infection. Further observation, If IgG is more than four times higher, acute or recent infection
IgM (+) / IgG (-) IgM (+) may be false positive. Keep testing. If results remain the same till the patient is recovered, IgM is confirmed to be false positive
IgM (-) / IgG (+) or IgM (+) / IgG (+)
IgM (-) / IgG (-) Negative.
If the IgG is more than four times higher, acute or recent infection
IgM (+) / IgG (+) or IgM (-) / IgG (+) Acute infection
All rights reserved. Specifications subject to change without prior notice
Version 2.1
Genrui Biotech Inc. Add: 4-10F, Building 3, Geya Technology Park, Guangming District, 518106, Shenzhen, China Tel: +86 755 26835560/1/2 Fax: +86 755 26678789 Website: www.genrui-bio.com